<DOC>
	<DOCNO>NCT02717754</DOCNO>
	<brief_summary>This multi-center , randomize , double-blind , multiple-dose , placebo-controlled , parallel-group study ass safety PK oseltamivir ( Tamiflu ) carboxylate metabolite , RO0640802 healthy participant . Participants randomize receive 100 milligram ( mg ) oseltamivir , 200 mg oseltamivir , placebo , administer intravenously twice daily ( BID ) . The anticipated time study treatment 5 day .</brief_summary>
	<brief_title>A Study Investigate Safety , Tolerability , Pharmacokinetics ( PK ) Oseltamivir Its Carboxylate Metabolite , RO0640802 Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Oseltamivir</mesh_term>
	<criteria>Participants Body Mass Index ( BMI ) 1834 kilogram per meter square ( kg/m^2 ) , inclusive Male participant willing use barrier contraception duration study 3 month follow end treatment Female participant nonchild bear potential Female participant child bear potential utilizing two effective method contraception duration study 3 month follow end treatment Evidence clinically significant disease disorder ( example , renal , cardiac , bronchopulmonary ) Any condition disease would place participant undue risk , interfere assessment , ability participant complete study Clinically significant orthostatic hypotension present screen history clinically significant hypotensive episode symptom faint , dizziness , lightheadedness . Participants abnormal electrocardiogram ( ECG ) , bradycardia mean QTc screen Positive result Hepatitis B , Hepatitis C , human immunodeficiency virus ( HIV ) 1 2 screen Renal impairment Transplant recipients A know clinically relevant history allergy hypersensitivity Any clinically relevant abnormal laboratory test result A clinically relevant history abuse alcohol drug abuse Any major illness within 30 day prior screen examination Smoking 10 cigarette day equivalent amount tobacco form cigar pipe Participation clinical study investigational drug within 3 month prior Day 1 Donation/loss 500 milliliter ( mL ) blood within 3 month prior Day 1 Positive pregnancy test screen Day 1 lactate woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>